Avelox and Creon drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Avelox (moxifloxacin hydrochloride) and Creon (pancrelipase (amylase;lipase;protease)). Common drug interactions include abdominal mass among females and infective pulmonary exacerbation of cystic fibrosis among males.
The phase IV clinical study analyzes what interactions people have when they take Avelox and Creon. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.
What is Avelox?
Avelox has active ingredients of moxifloxacin hydrochloride. It is often used in sinusitis. eHealthMe is studying from 28,651 Avelox users. Check the latest studies of Avelox.
What is Creon?
Creon has active ingredients of pancrelipase (amylase;lipase;protease). It is often used in pancreatitis. eHealthMe is studying from 29,489 Creon users. Check the latest studies of Creon.
32 people who take Avelox and Creon together, and have interactions are studied.

What are the common drug interactions of Avelox and Creon, by gender? *:
female:
- Abdominal mass (localized enlargement or swelling in the human abdomen)
- Abdominal pain
- Abdominal pain upper
- Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
- Acute left ventricular failure (heart attack)
- Acute respiratory failure
- Adenocarcinoma pancreas (cancer of pancreas)
- Arthralgia (joint pain)
- Ascites (accumulation of fluid in the abdominal cavity)
- Aspartate aminotransferase increased
male:
- Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
- Dyspnoea (difficult or laboured respiration)
- Adenocarcinoma pancreas (cancer of pancreas)
- Ascites (accumulation of fluid in the abdominal cavity)
- Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
- General physical health deterioration (weak health status)
- Productive cough
- Abscess limb (limb infection)
- Anaemia (lack of blood)
- Angiopathy (generic term for a disease of the blood vessels)
What are the common drug interactions of Avelox and Creon, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
- Cystic fibrosis (disease of the secretary glands)
20-29:
- Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
- Chest pain
- Dyspnoea (difficult or laboured respiration)
- Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
- Pancreatic atrophy
- Productive cough
- Pyrexia (fever)
- Tachycardia (a heart rate that exceeds the range of 100 beats/min)
- White blood cell count increased
30-39:
- Decreased appetite
- Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
- Femur fracture
- Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch)
- Nausea (feeling of having an urge to vomit)
- Thrombosis (formation of a blood clot inside a blood vessel)
- Tongue injury
- Tremor (trembling or shaking movements in one or more parts of your body)
- Wisdom teeth removal
40-49:
- Retching (strong involuntary effort to vomit)
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
- Skin papilloma (a general medical term for a tumour of the skin or mucous membrane with finger-like projections)
- Spinal pain (pain in spine)
- Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
- Urinary tract infection
- Urine output decreased
- Vaginal discharge
- Vomiting
- Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
50-59:
- Chronic kidney disease
- Adenocarcinoma pancreas (cancer of pancreas)
- Ascites (accumulation of fluid in the abdominal cavity)
- Asthenia (weakness)
- Bile duct obstruction (blockage in the tubes that carry bile from the liver to the gallbladder)
- Decreased appetite
- Fatigue (feeling of tiredness)
- Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
- Metastases to adrenals (cancer spreads to adrenal gland of kidney)
- Metastases to bone (cancer spreads to bone)
60+:
- Adenocarcinoma pancreas (cancer of pancreas)
- Ascites (accumulation of fluid in the abdominal cavity)
- Emotional distress
- Hepatic steatosis (fatty liver disease)
- Hepatitis fulminant (life-threatening condition defined by significantly impaired liver function)
- Hepatorenal syndrome (renal failure in patients with advanced chronic liver disease)
- Jaundice cholestatic
- Metastases to lymph nodes (cancer spreads to lymph node)
- Metastatic lymphoma (spreadable cancer tumour of lymph node)
- Osteoporosis (bones weak and more likely to break)
What are the existing conditions these people have? *
- Pain: 8 people, 25.00%
- Cystic Fibrosis (disease of the secretary glands): 6 people, 18.75%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 18.75%
- Cough: 4 people, 12.50%
- Nausea (feeling of having an urge to vomit): 3 people, 9.38%
- Immunodeficiency Common Variable: 3 people, 9.38%
- Infection: 3 people, 9.38%
- Infective Pulmonary Exacerbation Of Cystic Fibrosis (severe infective lung disease with production of abnormally thick mucus): 3 people, 9.38%
- Fever: 3 people, 9.38%
- High Blood Cholesterol: 3 people, 9.38%
* Approximation only. Some reports may have incomplete information.
Do you take Avelox and Creon?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Avelox and Creon:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Avelox:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Creon:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Avelox and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Creon and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on moxifloxacin hydrochloride and pancrelipase (amylase;lipase;protease) (the active ingredients of Avelox and Creon, respectively), and Avelox and Creon (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Fexofenadine Hydrochloride and Diphenhydramine Hydrochloride - now
- Could Intuniv cause Appetite Decreased? - a second ago
- Could Intuniv cause Appetite - Decreased? - a second ago
- Parkinsonism Aggravated and Idiopathic Pulmonary Fibrosis - 6 seconds ago
- Drug interactions of Olanzapine and Linezolid - 17 seconds ago
- Drug interactions of Daptomycin and Alendronate Sodium - 24 seconds ago
- Drug interactions of Crestor and Senna - 39 seconds ago
- Drug interactions of Metformin and Proventil - 40 seconds ago
- Could Requip cause Pancreatitis Acute? - a minute ago
- Could Sumatriptan Succinate cause Red Blood Cell Count Decreased? - a minute ago